Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04995094 |
| Title | Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | HiberCell, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UC San Diego Moores Cancer Center | La Jolla | California | 92093-0990 | United States | Details | |
| Innovative Clinical Research Institute | Whittier | California | 90603 | United States | Details | |
| Ichan School of Medicine at Mount Sinai | New York | New York | 10029 | United States | Details | |
| Allegheny Health Network | Pittsburgh | Pennsylvania | 15212 | United States | Details |